Non– AIDS ‐Defining Cancer Incidence in People With HIV in Milan, Italy, 2000–2023: Temporal Trends and Comparison With the General Population
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70689 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Giacomo Pozza und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy. Hauptthemen laut MEDLINE: Neoplasms, HIV Infections, Acquired Immunodeficiency Syndrome. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
People with HIV (PWH) are living longer, but contemporary data on non–AIDS‐defining cancers (NADCs) in Italy remain limited. We assessed incident cancers in a retrospective cohort of PWH in Milan, Italy, between January 2000 and December 2023. Follow‐up was grouped into 2000–2007, 2008–2015, and 2016–2023. Incidence rates (IRs) were calculated per 100,000 person‐years (PYs). Multivariable Poisson regression estimated adjusted (age, mode of HIV acquisition, and prior AIDS diagnosis) IR ratios (aIRRs) for first incident NADCs. Standardized incidence ratios (SIRs) compared observed cancers with expected cases in the general population. Among 4642 PWH contributing 50,086 PYs, 321 first incident NADCs were diagnosed. NADC incidence increased from 518 (95% CI 422–636) in 2000–2007 to 812 (95% CI 683–967) in 2016–2023. Non–virus‐related cancer incidence increased from 293 to 582 per 100,000 PYs, whereas virus‐related cancer incidence remained stable, from 225 to 230 per 100,000 PYs. People who inject drugs (PWID) versus heterosexuals (aIRR 1.71, 95% CI 1.33–2.20), and prior AIDS diagnosis (aIRR 1.33, 95% CI 1.05–1.69) were associated with higher NADC incidence. Compared with the general population, lung cancer incidence was increased in females (SIR 3.21, 95% CI 1.94–5.32). Anal cancer incidence was markedly elevated in both males and females (SIR 59.16, 95% CI 42.06–83.22 and 18.55, 95% CI 8.33–41.30, respectively). The excess cancer burden in this cohort was concentrated in selected NADCs, particularly anal cancer and, in females, lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
- Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy.
- Department of Oncology, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
- Multidisciplinary Action for Global Health (MAGH), University of Milan, Milan, Italy.
ORCID-Profile: Andrea Giacomelli
Zitieren
APA
Pozza, G., Matone, M., Oreni, L., Carrozzo, G., Caloni, B., Cossu, M. V., Moschese, D., Ridolfo, A. L., Gervasoni, C., Fasola, C., La Verde, N., Dalu, D., Antinori, S., Gori, A., & Giacomelli, A. (2026). Non– AIDS ‐Defining Cancer Incidence in People With HIV in Milan, Italy, 2000–2023: Temporal Trends and Comparison With the General Population. International Journal of Cancer. https://doi.org/10.1002/ijc.70689
Vancouver
Pozza G, Matone M, Oreni L, Carrozzo G, Caloni B, Cossu MV, et al. Non– AIDS ‐Defining Cancer Incidence in People With HIV in Milan, Italy, 2000–2023: Temporal Trends and Comparison With the General Population. International Journal of Cancer. 2026. doi:10.1002/ijc.70689
BibTeX
@article{Pozza2026,
author = {Pozza, Giacomo and Matone, Maddalena and Oreni, Letizia and Carrozzo, Giorgia and Caloni, Beatrice and Cossu, Maria Vittoria and Moschese, Davide and Ridolfo, Anna Lisa and Gervasoni, Cristina and Fasola, Cinzia and La Verde, Nicla and Dalu, Davide and Antinori, Spinello and Gori, Andrea and Giacomelli, Andrea},
title = {Non– AIDS ‐Defining Cancer Incidence in People With HIV in Milan, Italy, 2000–2023: Temporal Trends and Comparison With the General Population},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70689}
}
EUVIMED